The views of European clinicians on guidelines for long‐term follow‐up of childhood cancer survivors
Open Access
- 8 November 2014
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 62 (2) , 322-328
Abstract
Background: Evidence‐based guidelines are needed to guide effective long‐term follow‐up (LTFU) of childhood cancer survivors (CCS) at risk of late adverse effects (LAEs). We aimed to ascertain the use of LTFU guidelines throughout Europe, and seek views on the need for pan‐European LTFU guidelines.Procedures: One expert clinician from each of 44 European countries was invited to participate in an online survey. Information was sought regarding the use and content of LTFU guidelines in the respondent's centre and country, and their views about developing pan‐European LTFU guidelines.Results: Thirty‐one countries (70%) responded, including 24 of 26 full EU countries (92%). LTFU guidelines were implemented nationally in 17 countries (55%). All guidelines included recommendations about physical LAEs, specific risk groups and frequency of surveillance, and the majority about psychosocial LAEs (70%), and healthy lifestyle promotion (65%). A minority of guidelines described recommendations about transition to age‐appropriate LTFU services (22%), where LTFU should be performed (22%) and by whom (30%). Most respondents (94%) agreed on the need for pan‐European LTFU guidelines, specifically including recommendations about surveillance for specific physical LAEs (97%), action to be taken if a specific LAE is detected (90%), minimum requirements for LTFU (93%), transition and health promotion (both 87%).Conclusions: Guidelines are not universally used throughout Europe. However, there is strong support for developing pan‐European LTFU guidelines for CCS. PanCareSurFup (www.pancare.eu) will collaborate with partners to develop such guidelines, including recommendations for hitherto relatively neglected topics, such as minimum LTFU requirements, transition and health promotion. Pediatr Blood Cancer 2015;62:322–328.Keywords
Funding Information
- European Union's Seventh Framework Programme (257505)
- Swedish Childhood Cancer Foundation
- Swiss National Science Foundation (PZ00P3_121682/1, PZ00P3-141722)
- Dutch Cancer Society, Amsterdam, the Netherlands (UVA 2011-4938)
- Children's Cancer Fund, Newcastle upon Tyne, UK
This publication has 14 references indexed in Scilit:
- Late Complications of Cancer in Childhood and AdolescenceOncology & Hematology Review, 2013
- Follow-Up Programs for Childhood Cancer Survivors in Europe: A Questionnaire SurveyPLOS ONE, 2012
- Effects of evidence-based clinical practice guidelines on quality of care: a systematic reviewQuality and Safety in Health Care, 2009
- Survival of European children and young adults with cancer diagnosed 1995–2002European Journal of Cancer, 2009
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how?Archives of Disease in Childhood, 2007
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Long-term follow-up of people who have survived cancer during childhoodThe Lancet Oncology, 2006
- Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelinesBMJ, 1999
- Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluationsThe Lancet, 1993